Quick response of advanced cancer to chemoradiation therapy with antineoplastons.

  • Authors:
    • H Tsuda
    • M Sata
    • T Kumabe
    • H Hara
    • N Eriguchi
    • Y Sugita
    • H Nagamatsu
  • View Affiliations

  • Published online on: May 1, 1998     https://doi.org/10.3892/or.5.3.597
  • Pages: 597-1197
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Antineoplastons A10 and AS2-1 exhibit growth inhibition of cancer cells by diverse modes of action. We observed antitumor responses within 2-3 weeks of a combination treatment of chemoradiation therapy and antineoplastons A10 and AS2-1 in phase I clinical study being conducted in Kurume University Hospital. We reviewed 3 clinical cases of advanced cancer (multiple metastatic lung cancer, thalamic glioma and primary lung cancer) in which we believed antineoplaston A10 and AS2-1 may be contributing to the rapid antitumor response. The possible use of this combination for induction therapy in advanced cancer is discussed.

Related Articles

Journal Cover

May 1998
Volume 5 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Tsuda, H., Sata, M., Kumabe, T., Hara, H., Eriguchi, N., Sugita, Y., & Nagamatsu, H. (1998). Quick response of advanced cancer to chemoradiation therapy with antineoplastons.. Oncology Reports, 5, 597-1197. https://doi.org/10.3892/or.5.3.597
MLA
Tsuda, H., Sata, M., Kumabe, T., Hara, H., Eriguchi, N., Sugita, Y., Nagamatsu, H."Quick response of advanced cancer to chemoradiation therapy with antineoplastons.". Oncology Reports 5.3 (1998): 597-1197.
Chicago
Tsuda, H., Sata, M., Kumabe, T., Hara, H., Eriguchi, N., Sugita, Y., Nagamatsu, H."Quick response of advanced cancer to chemoradiation therapy with antineoplastons.". Oncology Reports 5, no. 3 (1998): 597-1197. https://doi.org/10.3892/or.5.3.597